Browse News
Filter News
Found 41 articles
-
Virta Health Announces First-of-its-Kind Peer-Reviewed Study Proving Its Approach Is an Effective Off-Ramp From GLP-1s for Sustained Weight Loss
2/29/2024
Virta Health has released first-of-its-kind, peer-reviewed data demonstrating the company’s approach to personalized nutrition therapy results in sustained weight loss after the discontinuation of glucagon-like peptide-1 receptor agonists, including Ozempic.
-
Digital Therapeutics Market - The Health Benefits and Business Potential
12/7/2023
Digital-native start-ups and healthcare incumbents can both play important roles in building and scaling digital therapeutics to improve the management of chronic health conditions.
-
Capital Rx Launches Rx Reverse in Partnership with Virta Health to Combat Type 2 Diabetes and Obesity
7/17/2023
Capital Rx, the health technology company changing the way prescription drugs are priced and patients are cared for, and type 2 diabetes reversal leader Virta Health have partnered to introduce Rx Reverse.
-
MedSec Announces Formation of New Technical Advisory Board
6/6/2023
MedSec, a leading medical device security services firm, announced the formation of its Technical Advisory Board.
-
mHealth Market: Increasing Prevalence of Chronic Diseases to Drive the Market
8/12/2022
Wilmington, Delaware, United States, Transparency Market Research Inc. – Mobile technology has expanded significantly across the globe in recent years.
-
Baszucki Brain Research Fund Backs First Clinical Pilot Trials of Ketogenic Metabolic Interventions for Mental Health Conditions in Nearly 60 Years
7/18/2022
The Baszucki Brain Research Fund is pleased to announce that five science teams around the globe have received funding to study ketogenic metabolic interventions for bipolar disorder, schizophrenia and major depressive disorder.
-
Virta Health Highlights Lasting, Transformative Health Improvements In 5-Year Diabetes Reversal Study
6/6/2022
Virta Health, the leader in type 2 diabetes reversal, revealed preliminary five-year results from its landmark clinical trial at the American Diabetes Association 82nd Scientific Sessions.
-
mHealth Monitoring Diagnostic Medical Devices Market Size to Surpass US$ 165 BN by 2030
6/2/2022
According to Vision Research Reports, the global mHealth Monitoring Diagnostic Medical Devices market size was surpassed US$ 32 Bn in 2021 and is expected to grow at a CAGR of 21% from 2022 to 2030.
-
Type 2 Diabetes Reversal Leader Virta Health Appoints Shane Henderson as Chief Technology Officer
5/10/2022
Diabetes reversal leader Virta Health announced the addition of Shane Henderson as Chief Technology Officer.
-
mHealth Monitoring Diagnostic Medical Devices Market Size, Growth, Report 2022-2030
5/2/2022
The global mHealth monitoring diagnostic medical devices market for the historical period 2017–2018 and forecast period 2019–2027, rise in prevalence of chronic disorders, aging population, technological advancements, entry of new players, and increase in access to health care are projected to drive the global mHealth monitoring diagnostic medical devices market.
-
CORRECTING and REPLACING GRAPHIC Diabetes Reversal Leader Virta Health Earns Validation Institute’s Highest Ranking for Delivering Industry-Leading Prescription Drug Savings
4/4/2022
Virta Health, the leader in type 2 diabetes reversal, earned the Validation Institute’s most prominent, Level 1 savings validation for delivering unmatched medication cost reductions.
-
Diabetes Reversal Leader Virta Health Earns Validation Institute’s Highest Ranking for Delivering Industry-Leading Prescription Drug Savings
4/4/2022
Virta Health, the leader in type 2 diabetes reversal, earned the Validation Institute’s most prominent, Level 1 savings validation for delivering unmatched medication cost reductions.
-
Nectar Secures $8M in Seed Funding to Revolutionize Allergy Care
3/17/2022
Nectar, an innovative and comprehensive allergy care platform, announced their $8 million seed round led by Juxtapose and Obvious Ventures, who are co-building the company alongside Founder and CEO Kenneth Chahine, Ph.D.
-
Digital Therapeutic Devices Market to Reach US$2,082.3 Mn By 2025-end, increasing prevalence of diabetes to drive the market
3/16/2022
The global digital therapeutic devices market is divided among a large number of players that features stiff competition, notes a fresh market study by Transparency Market Research.
-
Preclinical models indicate that pairing specific cancer treatments with precision nutritional interventions increased treatment efficacy by as much as 500%.
-
Diabetes Reversal Leader Virta Health Demonstrates Promising Results on Mitigating COVID-19 Severity for People with Type 2 Diabetes
6/28/2021
Virta Health, the leader in type 2 diabetes reversal, announced promising results on the ability of its treatment to mitigate COVID-19 severity.
-
Diabetes Reversal Leader Virta Health Raises $133M Series E to Take Type 2 Diabetes Reversal Mainstream
4/19/2021
Led by Tiger Global, the financing values Virta at $2 billion and signals a shift in type 2 diabetes care toward long-term disease reversal powered by next-generation telehealth
-
Diabetes Reversal Leader Virta Health Appoints Chief Financial Officer
2/3/2021
Virta Health, the type 2 diabetes reversal leader, today announced the appointment of Alok Bhushan to Chief Financial Officer.
-
Virta Health Raises $65 Million Series D to Scale Type 2 Diabetes Reversal Treatments
12/2/2020
Virta Health, the first company dedicated to reversing type 2 diabetes without medications or surgery, today announced that it has raised $65 million in Series D funding. Led by Sequoia Capital Global Equities , the financing will support the growing demand for Virta’s reversal treatments for type 2 diabet
-
Virta Health Partners With St. Louis Area Business Health Coalition to Expand Access to Type 2 Diabetes Reversal Treatment
8/26/2020
Today, Virta Health , the first company with a treatment to sustainably reverse type 2 diabetes (T2D) without medications or surgery, announced a partnership with the St. Louis Area Business Health Coalition (BHC), a non-profit organization representing over 70 forward-thinking employers that provide health benefits to